Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Researchers with Baylor College of Medicine and Texas A&M AgriLife Research collaborated with the U.S. Department of ...

In this Opinion article, the authors propose that the immunological process that underlies type 1 diabetes is relapsing–remitting in nature; they highlight the supporting evidence and the ...

Among patients with relapsing–remitting multiple sclerosis, daclizumab HYP showed efficacy superior to that of interferon beta-1a with regard to the annualized relapse rate and lesions, as ...

Fumarate therapies are equally effective among Black, Hispanic, Asian, and white people with relapsing forms of MS, a real-world study shows.

Relapsing MS is the most common form of multiple sclerosis. About 85% of people with MS at least start out with a relapsing form. A relapse is a problem that comes on fairly rapidly, not abruptly ...

The Committee discussed the clinical-effectiveness evidence from the trials. The Committee understood that the marketing authorisation included all people with relapsing–remitting multiple sclerosis, ...

Scientists at Texas A&M AgriLife Research and Baylor College of Medicine have sequenced the genome of the disease-spreading soft tick.